Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 GBX | -12.50% | 0.00% | -94.19% |
Mar. 21 | Esken in administration as restructuring no longer "viable" | AN |
Mar. 21 | Esken to enter administration as restructuring no longer "viable" | AN |
Sales 2024 * | 109M 138M | Sales 2025 * | 125M 157M | Capitalization | 715K 902K |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.64 x |
Net Debt 2024 * | 287M 363M | Net Debt 2025 * | 280M 353M | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
-0.01
x | P/E ratio 2025 * |
-0.02
x | Employees | 716 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.08% |
Latest transcript on Esken Limited
1 day | -12.50% | ||
Current month | -53.33% | ||
1 month | -60.00% | ||
3 months | -94.34% | ||
6 months | -97.59% | ||
Current year | -94.19% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 51 | 17-10-31 | |
John Cawrey
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-04-30 |
Adam Davidson
IRO | Public Communications Contact | - | 23-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Shearer
CHM | Chairman | 65 | 19-05-31 |
Director of Finance/CFO | 51 | 17-10-31 | |
Ginny Pulbrook
BRD | Director/Board Member | - | 18-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-21 | 0.07 | -12.50% | 3,352,719 |
24-03-20 | 0.08 | -1.96% | 2,500,234 |
Delayed Quote London S.E., March 21, 2024 at 04:45 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-94.19% | 902K | |
+11.18% | 29.54B | |
+8.79% | 12.05B | |
+5.41% | 9.52B | |
-9.92% | 8.16B | |
-5.11% | 7.34B | |
+16.51% | 7.02B | |
+1.30% | 5.78B | |
+34.51% | 3.49B | |
-5.45% | 2.8B |